Nucleoside cyclicphosphates

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8759510
APP PUB NO 20120258928A1
SERIAL NO

13439991

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Cyclic phosphate of nucleoside derivatives for the treatment of viral infections in mammals, which is a compound, its stereoisomers, salts (acid or basic addition salts), hydrates, solvates, or crystalline forms thereof, represented by the following structure:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • GILEAD PHARMASSET LLC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Du, Jinfa New Hope, US 59 1892
Nagarathnam, Dhanapalan Bethany, US 86 1995
Pamulapati, Ganapati Reddy Plainsboro, US 23 1108
Ross, Bruce S Plainsboro, US 22 1283
Sofia, Michael Joseph Doylestown, US 37 2348

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 24, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00